Funding to stop Candida auris lacking

July 16, 2019

Scientists who work in mycology — the study of fungi — say there is precious little money available to study Candida auris, according to an article on the STAT News website.

Candida auris is making news for its ability to resist multiple antifungal drugs and settle into hospital rooms so persistently it can take renovations to get rid of it.

The head of mycotic diseases at the Centers for Disease Control and Prevention (CDC) acknowledged his field hasn’t attracted the same kind of research dollars as other pathogens.

A high proportion of people who have been diagnosed with C. auris have died — the CDC estimates it’s between 30 percent and 60 percent.

Read the article.

See the latest posts on our homepage


Share

Topic Area: Infection Control


Recent Posts
Recent Posts

Rise of Delta Variant Puts Facilities on Notice


More-harmful coronavirus variant probably will become dominant U.S. strain in the coming months, Walensky says

6/23/2021

Wanted: A 21st Century IAQ Strategy


Managers need to consider holistic integrated IAQ solution that uses complementary technologies

6/23/2021

UC Irvine Gets OK for $1 Billion Hospital Campus


Campus will house 144-bed acute care facility, ambulatory care center and cancer center

6/23/2021

UC-Davis Construction Addresses Seismic Demands


Square footage of new hospital will be nearly double to accomodate more private rooms

6/22/2021

OSHA Cites Medical Facilities Owner Over COVID-19


Owner accused of failing to protect workers from exposure to virus and implement proper safety measures

6/22/2021





Post Comment




FREE
NEWSLETTER

News & Updates • Webcast Alerts • Building Technologies

All fields are required.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.